AlloVir Inc. (ALVR) Social Stream
Allovir Inc (ALVR) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ALVR.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 4 | $55 | $37 | $45 | $7.06 | 537.39% |
| 2021-12-13 | 4 | $55 | $36 | $44 | $7.06 | 523.23% |
| 2021-12-19 | 4 | $55 | $32 | $42.75 | $7.06 | 505.52% |
| 2022-01-18 | 4 | $55 | $32 | $42 | $7.06 | 494.9% |
| 2022-01-31 | 4 | $55 | $32 | $38.75 | $7.06 | 448.87% |
| 2022-02-11 | 4 | $55 | $30 | $37.5 | $7.06 | 431.16% |
The Trend in the Analyst Price Target
Over the past 28 weeks, ALVR's average price target has gone down $11.5.
ALVR reports an average of 171.99% for its upside potential over the past 43 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-04-14 | 1 | 55 | 41 | 48.00 | 23.56 | 103.74% |
| 2021-05-15 | 3 | 55 | 42 | 49.00 | 24.00 | 104.17% |
| 2021-05-21 | 3 | 55 | 42 | 49.00 | 21.57 | 127.17% |
| 2021-08-04 | 3 | 55 | 42 | 49.00 | 19.67 | 149.11% |
| 2021-09-04 | 3 | 55 | 40 | 45.75 | 20.21 | 126.37% |
ALVR Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.13 | 3 | 1 | 0 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 18 months, ALVR's average broker recommendation rating worsened by 0.25.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ALVR as an investment opportunity.
- Allovir Inc's upside potential (average analyst target price relative to current price) is greater than 578.33% of all US stocks.
- ALVR has a higher number of analysts covering the stock than 114.48% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, Allovir Inc's variance in analysts' estimates is lower than -305.89% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Allovir Inc's average analyst price target is greater than 376.76% of them.
In the Pharmaceutical Products industry, ALLO, AERI, and ADGI are the three stocks most similar to Allovir Inc regarding the price target and analyst recommendation information presented here.
Is ALVR a Buy, Hold or Sell? See the POWR Ratings now!